| NDC Code | 44911-0429-1 |
|---|
| Package Description | 30 mL in 1 BOTTLE, DROPPER (44911-0429-1) |
|---|
| Product NDC | 44911-0429 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Spleenex |
|---|
| Proprietary Name Suffix | V |
|---|
| Non-Proprietary Name | Aralia Quinquefolia, Magnesium Gluconicum Dihydricum, Potassium Gluconate, Ginkgo Biloba, Pancreas Suis, Spleen (suis), Stomach (suis), Germanium Sesquioxide, Cuprum Metallicum, Zincum Metallicum, Alpha-ketoglutaricum Acidum, Citricum Acidum, Fumaricum Acidum, Magnesia Phosphorica, Malicum Acidum, Pyruvic Acid, Succinicum Acidum, Naphthochinonum, Aconiticum Acidum, Cis-, Natrum Oxalaceticum |
|---|
| Dosage Form | LIQUID |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20170608 |
|---|
| End Marketing Date | 20220718 |
|---|
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
|---|
| Manufacturer | Energique, Inc. |
|---|
| Substance Name | ACONITIC ACID, (Z)-; AMERICAN GINSENG; ANHYDROUS CITRIC ACID; COPPER; FUMARIC ACID; GERMANIUM SESQUIOXIDE; GINKGO; MAGNESIUM GLUCONATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MALIC ACID; NAPHTHOQUINE; OXOGLURIC ACID; POTASSIUM GLUCONATE; PYRUVIC ACID; SODIUM DIETHYL OXALACETATE; SUCCINIC ACID; SUS SCROFA PANCREAS; SUS SCROFA SPLEEN; SUS SCROFA STOMACH; ZINC |
|---|
| Strength | 12; 3; 8; 8; 8; 8; 6; 3; 8; 8; 9; 8; 3; 8; 12; 8; 6; 6; 6; 8 |
|---|
| Strength Unit | [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
|---|
| Pharmacy Classes | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Coagulation Factor Activity [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
|---|